Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science · 31.07.2025 · 389 (6759)
DOI: 10.1126/science.adv5572 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Science, erschienen am 31.07.2025. Verfasst von Tom G Caniels und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, location AMC, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: AIDS Vaccines, Antibodies, Monoclonal, Broadly Neutralizing Antibodies, env Gene Products, Human Immunodeficiency Virus. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gates Foundation, NIAID NIH HHS.
Abstract (Originalsprache)
A protective HIV vaccine will need to induce broadly neutralizing antibodies (bnAbs) in humans, but priming rare bnAb precursor B cells has been challenging. In a double-blinded, placebo-controlled phase 1 human clinical trial, the recombinant, germline-targeting envelope glycoprotein (Env) trimer BG505 SOSIP.v4.1-GT1.1, adjuvanted with AS01 B , induced bnAb precursors of the VRC01-class at a high frequency in the majority of vaccine recipients. These bnAb precursors, which target the CD4 receptor binding site, had undergone somatic hypermutation characteristic of the VRC01-class. A subset of isolated VRC01-class monoclonal antibodies neutralized wild-type pseudoviruses and was structurally extremely similar to bnAb VRC01. These results further support germline-targeting approaches for human HIV vaccine design and demonstrate atomic-level manipulation of B cell responses with rational vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, location AMC, Amsterdam, Netherlands.
- Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
ORCID-Profile: Tom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski, Kellie J MacPhee, Weiwei Wu, Karlijn van der Straten, Sashank Agrawal, Emma I M M Reiss, Katrina Millard, Martina Turroja, Aimee Desrosiers, Elissa Malkin, Michelle Klouwens, Jonne L Snitselaar, Joey H Bouhuijs, Rhianna Bronson, Jalen Jean-Baptiste, Suprabhath Gajjala, Zahra Rikhtegaran Tehrani, Alison Benner, Mukundhan Ramaswami, Michael O Duff, Yung-Wen Liu, Alicia H Sato, Ju Yeong Kim, Isabel J L Baken, Catarina Mendes Silva, Albert Cupo, Anila Yasmeen, Swastik Phulera, Wen-Hsin Lee, Shiyu Zhang, Martin M Corcoran, David M Brown, Hongmei Gao, Nicole L Yates, Sheetal Sawant, Neeltje A Kootstra, Stephen M Kaminsky, Farhad Rahaman, Margaret Meller, Vince Philiponis, Dagna S Laufer, Angela Lombardo, Lindsey Mwoga, Solmaz Shotorbani
Förderung
- Gates Foundation
- NIAID NIH HHS
Zitieren
APA
Caniels, T. G., Prabhakaran, M., Ozorowski, G., MacPhee, K. J., Wu, W., van der Straten, K., Agrawal, S., Derking, R., Reiss, E. I. M. M., Millard, K., Turroja, M., Desrosiers, A., Bethony, J., Malkin, E., Liesdek, M. H., van der Veen, A., Klouwens, M., Snitselaar, J. L., Bouhuijs, J. H., …, & Shotorbani, S. (2025). Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, 389(6759). https://doi.org/10.1126/science.adv5572
Vancouver
Caniels TG, Prabhakaran M, Ozorowski G, MacPhee KJ, Wu W, van der Straten K, et al. Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science. 2025;389(6759). doi:10.1126/science.adv5572
BibTeX
@article{Caniels2025,
author = {Caniels, Tom G and Prabhakaran, Madhu and Ozorowski, Gabriel and MacPhee, Kellie J and Wu, Weiwei and van der Straten, Karlijn and Agrawal, Sashank and Derking, Ronald and Reiss, Emma I M M and Millard, Katrina and Turroja, Martina and Desrosiers, Aimee and Bethony, Jeffrey and Malkin, Elissa and Liesdek, Marinus H and van der Veen, Annelou and Klouwens, Michelle and Snitselaar, Jonne L and Bouhuijs, Joey H and Bronson, Rhianna and Jean-Baptiste, Jalen and Gajjala, Suprabhath and Rikhtegaran Tehrani, Zahra and Benner, Alison and Ramaswami, Mukundhan and Duff, Michael O and Liu, Yung-Wen and Sato, Alicia H and Kim, Ju Yeong and Baken, Isabel J L and Mendes Silva, Catarina and Bijl, Tom P L and van Rijswijk, Jacqueline and Burger, Judith A and Cupo, Albert and Yasmeen, Anila and Phulera, Swastik and Lee, Wen-Hsin and Randall, Kipchoge N and Zhang, Shiyu and Corcoran, Martin M and Regadas, Isabel and Sullivan, Alex C and Brown, David M and Bohl, Jennifer A and Greene, Kelli M and Gao, Hongmei and Yates, Nicole L and Sawant, Sheetal and Prins, Jan M and Kootstra, Neeltje A and Kaminsky, Stephen M and Barin, Burc and Rahaman, Farhad and Meller, Margaret and Philiponis, Vince and Laufer, Dagna S and Lombardo, Angela and Mwoga, Lindsey and Shotorbani, Solmaz},
title = {Precise targeting of HIV broadly neutralizing antibody precursors in humans},
journal = {Science},
year = {2025},
volume = {389},
number = {6759},
doi = {10.1126/science.adv5572}
}
EUVIMED